Carol Aghajanian
- Reproductive Medicine top 0.02%
- Oncology top 0.2%
- Obstetrics and Gynecology top 0.05%
- Molecular Biology top 2%
- Surgery top 0.5%
- Co-authors
- David R. SpriggsPaul SabbatiniRichard R. BarakatNadeem R. Abu‐RustumMartee L. HensleyS. DennisAlexia IasonosAmreen Husain
- Topics
- Ovarian cancer diagnosis and treatment (262 papers)Endometrial and Cervical Cancer Treatments (111 papers)PARP inhibition in cancer therapy (70 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Carol Aghajanian
412 papers receiving 15.1k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Reproductive Medicine 7.5k
- Oncology 6.1k
- Obstetrics and Gynecology 4.3k
- Molecular Biology 3.6k
- Surgery 3.2k
Countries citing papers authored by Carol Aghajanian
This map shows the geographic impact of Carol Aghajanian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol Aghajanian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol Aghajanian more than expected).
Fields of papers citing papers by Carol Aghajanian
This network shows the impact of papers produced by Carol Aghajanian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol Aghajanian. The network helps show where Carol Aghajanian may publish in the future.
Co-authorship network of co-authors of Carol Aghajanian
This figure shows the co-authorship network connecting the top 25 collaborators of Carol Aghajanian. A scholar is included among the top collaborators of Carol Aghajanian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol Aghajanian. Carol Aghajanian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 4 | |
| 5 | 2 | |
| 6 | 16 | |
| 7 | 62 | |
| 8 | Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancerbreakdown → | 359 |
| 9 | Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Studybreakdown → | 224 |
| 10 | Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early-Stage Endometrial Cancerbreakdown → | 209 |
| 11 | 23 | |
| 12 | 22 | |
| 13 | 88 | |
| 14 | 29 | |
| 15 | 60 | |
| 16 | OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancerbreakdown → | 970 |
| 17 | 68 | |
| 18 | 214 | |
| 19 | 88 | |
| 20 | 44 |
About Carol Aghajanian
Carol Aghajanian is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology, having authored 425 papers that have together received 15.3k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (262 papers), Endometrial and Cervical Cancer Treatments (111 papers) and PARP inhibition in cancer therapy (70 papers). The work is most often cited by research in Reproductive Medicine (7.5k citations), Obstetrics and Gynecology (4.3k citations) and Oncology (6.1k citations). Carol Aghajanian has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include David R. Spriggs, Paul Sabbatini, Richard R. Barakat, Nadeem R. Abu‐Rustum, Martee L. Hensley, S. Dennis, Alexia Iasonos, Amreen Husain, Barbara A. Goff and Lawrence R. Nycum. Their work appears in journals such as Cell, Journal of Clinical Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.